Most patients who have periodontitis respond to routine management, which can include scaling and root planning, periodontal flap surgery (regenerative or respective) and, when treatment fails, the placement of endosseous implants.
In general 80% of patients will respond to routine therapy, but the problem remains: what do we do about those who do not respond? Are there new developments currently available or on the horizon that will also later what we now accept as being routine therapy, meaning that more patients will respond to treatment and that treatment might either be less invasive, or more predictable, or both?
There is mounting evidence that patients who so-called refractory periodontitis might be hyper-immune. As such, novel approaches to managing these patients will likely include host modulation therapy (using a collagenase inhibitor such as Periostat®), anti-inflammatory treatment (in combination with host modulation therapy), both of which can be combined with mechanical treatment (scaling and root planning and /or surgery) to effect better outcomes.
- Understand refractory periodontitis and the novel approaches available for better outcomes
- Review the administration and side effects of both systemic and locally administered antimicrobial (LAAs)
- Identify the needs for adjunctive topical therapies for the patient when clinical improvements of periodontitis have been observed
- Identify new trends in therapy, their potential for complications and the potential for a novel approach to managing periodontitis
- Understand how novel periodontal therapies might impact general health
The speaker will answer your questions
There are no commnets, questions or opinions posted yet. Be the first to comment on this course, it's easy! Just use the box below to write your message and the click "Post"
Howard Tenenbaum, DDS, Dip Perio, PhD, FRCD(C)
Dr. Tenenbaum received his D.D.D. from the University of Toronto in 1978 and then completed his specialty in Periodontology as well as a Ph.D. in bone cell biology by 1982. This was followed by a 2-year post-doctoral MRC fellowship in Bethesda at the National Institutes of Health. In addition to his degrees, Dr. Tenenbaum has a Fellowship from the Royal College of Dentists of Canada, as well as the International College of Dentists and the Academy of Dentistry International.
Dr. Tenenbaum is a Professor of Periodontology, and was Head of that Discipline for 8 years (1997-2005), at the Faculty of Dentistry, University of Toronto. He was also Associate Dean for Biological and Diagnostic Sciences for 6 years having just stepped down September 2007 to pursue his research more actively. He is a cross-appointed Professor in the Department of Laboratory Medicine and Pathophysiology, Faculty of Medicine, University of Toronto and is the Head of the Division of Research in the Department of Dentistry at Mount Sinai Hospital. Dr. Tenenbaum also serves as an FDA panel member for Dental Devices and Drugs (USA) and is Vice-Chair of the Federal Dental Care Advisory Committee (Canada).
Dr. Tenenbaum has had research funding from the Medical Research Council of Canada, CIHR (Canadian Institutes for Health Research) and other agencies for the past 25-years and has pursued ongoing research in the fields of bone cell biology, periodontics, and orofacial pain. He has lectured nationally and internationally on several topics including orofacial pain and management of refractory periodontal diseases.
Density is at the threshold of laser technology which is starting to have a profound impact on the way we practice today.
Periodontal Disease and Diabetes: A Two-Way Street to Health Through Interdisciplinary CollaborationDonna Jornsay, Registered Nurse, Nurse Practitioner, Certified Diabetes Educator / Lauren Gueits, Registered Dental Hygienist
The association between periodontal disease and cardiovascular and cerebrovascular diseases has been demonstrated by many studies. These stu
Periodontal disease is one the most common chronic conditions affecting patients and populations. Accordingly, the disease is initiated by e
From this course you will learn, the laser physics, tissue interactions, new technologies available and how to consider implementing lasers